SIRION Biotech Participates In Gene Therapy Expert Panel Discussion At The Piper Jaffray GenomeRx Symposium

SIRION Biotech GmbH, enables its customers to advance the field of gene therapy through multiple proprietary viral vector platforms. Today the company announced that its Chief Technology Officer, Christian Thirion, Ph.D. participated on a panel on Monday with leading gene therapy industry experts covering the regulatory needs in clinical development at the Piper Jaffray GenomeRx Symposium, at the Yale Club in New York City.

Help employers find you! Check out all the jobs and post your resume.